Accidental Ixazomib Overdose in a Patient With Multiple Myeloma

• Main Authors: Parth J. Sampat MBBS (Author), Maneesh Bisen MD (Author), Nimisha Srivastava MD (Author), Suman Rao MD (Author), Teresa Gentile MD (Author)
• Format: Book
• Published: SAGE Publishing, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Multiple myeloma is the second most common hematological malignancy. Ixazomib is the first oral proteasome inhibitor approved in the United States for the management of multiple myeloma who have received at least one prior treatment. The availability of oral chemotherapeutic agents for the managemen...